Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics goes genomic.

David B Goldstein1, Sarah K Tate, Sanjay M Sisodiya

  • 1Department of Biology (Galton Laboratory), University College London, The Darwin Building, Gower Street, London WC1E 6BT, UK. d.goldstein@ucl.ac.uk

Nature Reviews. Genetics
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

JAMA network open·2026
Same author

The impact of TRPV4 pathogenic mutations on barrier integrity.

Human molecular genetics·2025
Same author

RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS.

Nature communications·2025
Same author

Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.

Journal of the American Society of Nephrology : JASN·2024
Same author

Do germline genetic variants influence surgical outcomes in drug-resistant epilepsy?

Epilepsy research·2024
Same author

Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS.

BMC genomics·2024
Same journal

Genetic origins and constraints of evolutionary innovation.

Nature reviews. Genetics·2026
Same journal

Single-cell four-omics with CHARM.

Nature reviews. Genetics·2026
Same journal

Molecular integration of seasonal temperature signals in flowering time control.

Nature reviews. Genetics·2026
Same journal

RBPscan measures protein-RNA interactions in living cells.

Nature reviews. Genetics·2026
Same journal

Revisiting retinal and macular degeneration in the genomics era.

Nature reviews. Genetics·2026
Same journal

How evolution builds three morphs from one genome.

Nature reviews. Genetics·2026
See all related articles

Pharmacogenetics tailors drug therapy to individual genetic makeup, reducing varied responses and adverse reactions to medications. This personalized approach maximizes the public health benefits of genetic research.

Area of Science:

  • Pharmacology
  • Genetics
  • Personalized Medicine

Background:

  • Most individuals in developed nations receive prescription drugs for common diseases or prevention.
  • Medication efficacy and adverse reactions vary significantly among individuals.
  • Understanding genetic influences on drug response is crucial for improving patient outcomes.

Purpose of the Study:

  • To introduce pharmacogenetics as a strategy to minimize inter-individual variability in drug response.
  • To highlight the potential of pharmacogenetics in realizing the public health benefits of the Human Genome Project.

Main Methods:

  • This field relies on analyzing an individual's genetic makeup.
  • It involves correlating genetic variations with drug metabolism and therapeutic effects.

Related Experiment Videos

  • Research integrates genomic data with clinical pharmacology.

    • Main Results:

    • Pharmacogenetics identifies genetic factors influencing drug efficacy and toxicity.
    • It enables the prediction of individual responses to specific medications.
    • Tailoring drug therapy based on genetic profiles can optimize treatment outcomes.

    Conclusions:

    • Pharmacogenetics offers a powerful approach to personalize medicine.
    • Investment in pharmacogenetics is key to translating genomic discoveries into tangible public health benefits.
    • This field promises to enhance drug safety and effectiveness for diverse patient populations.